Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-24 @ 4:25 PM
Ignite Modification Date: 2025-12-24 @ 4:25 PM
NCT ID: NCT06737666
Eligibility Criteria: Inclusion Criteria: * IBS-D patients and healthy volunteers meeting diagnostic criteria; * Aged between 18 and 70; * Have not taken antibiotics, steroids and other hormones, Chinese herbal preparations (including oral and intravenous injections), microecological preparations or probiotics such as yogurt in the past week. * Patients sign informed consent forms and are willing to receive appropriate treatment, and volunteers are willing to cooperate in taking blood, urine, stool and other samples. Exclusion Criteria: * Patients with serious heart, liver, kidney and other major organ diseases, hematopoietic system, nervous system or mental diseases; * Other organic diseases of the digestive system (such as peptic ulcers), organic diseases such as tumors indicated by recent colonoscopy, or systemic diseases affecting digestive motility (such as hyperthyroidism, diabetes); * Need to continue to use drugs that may affect gastrointestinal function (antidiarrheals, antidepressants, anti-anxiety drugs, intestinal flora regulation drugs, antibiotics, etc.); * Have a history of drug allergy or severe food allergy for research purposes; * Patients under 18 years of age or over 75 years of age and pregnant or lactating women; * Severe negative life events occurred during treatment; * There is currently any form of psychotherapy in progress; * No intention to cooperate.
Healthy Volunteers: True
Sex: ALL
Minimum Age: 18 Years
Maximum Age: 70 Years
Study: NCT06737666
Study Brief:
Protocol Section: NCT06737666